PRESTO’s primary aim is to accelerate European progress towards a better understanding of the role of P2XRs and eATP in the pathogenesis of inflammatory, infectious, neurologic and oncologic diseases and to foster the development and translation to the clinics of P2XR-targeting therapies.
PRESTO has brought together 167 members from 28 different countries.
All participants are working together towards a common goal, utilizing their skills and expertise to drive the project forward.
The project has a strong and diverse team that is working towards advancing research and achieving its objectives.
Whether as a leader of a working group or as a coordinator of grant awarding, each person is making PRESTO a success!
